Ifabotuzumab | m-entrepreneurship.com

Product Name :
Ifabotuzumab

Search keywords :
EPHA3

drugId :
null

Target Vo:
Ephrin type-A receptor 3

Target Vo Short Name :
EphA3

Moa_Name:
Ephrin type-A receptor 3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ludwig Institute For Cancer Research

Active Company_Name :
Olivia Newton-John Cancer Research Institute

Active Indication_Name:
Glioblastoma

In Active Indication_Name:
Primary Myelofibrosis

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JunB Antibody
PKC alpha Antibody
PTGES2 Antibody: PTGES2 Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-PTGES2 polyclonal antibody. PTGES2 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow background without labeling.

Author: Betaine hydrochloride

Related Posts